Cancer Immunol. Immunother.

ISSN	1432-0851
ISSN-L	0340-7004
IUID	b751edffef704aa8abadc3c6d43c26b1
Modified	2020-11-27T13:12:53.665Z
Created	2018-12-05T11:02:40.072Z

Year 2025

PubMed DOI Crossref

Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas.

Ma J, Sarén T, Jin C, ..., Yu D, Essand M

Cancer Immunol. Immunother. 74 (8) 262 [2025-07-12; online 2025-07-12]

Year 2022

PubMed DOI Crossref

Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden.

Femel J, van Hooren L, Herre M, ..., Dimberg A, Olsson AK

Cancer Immunol. Immunother. 71 (10) 2581 [2022-10-00; online 2022-03-01]

PubMed DOI Crossref

Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden.

Femel J, van Hooren L, Herre M, ..., Dimberg A, Olsson AK

Cancer Immunol. Immunother. 71 (8) 2029-2040 [2022-08-00; online 2022-01-11]

Year 2021

PubMed DOI Crossref

Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells.

Van der Meer JMR, Maas RJA, Guldevall K, ..., Hobo W, Dolstra H

Cancer Immunol. Immunother. 70 (11) 3367 [2021-11-00; online 2021-09-16]

PubMed DOI Crossref

Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy.

Wenthe J, Naseri S, Labani-Motlagh A, ..., Loskog A, Lövgren T

Cancer Immunol. Immunother. 70 (10) 2851-2865 [2021-10-00; online 2021-03-05]

PubMed DOI Crossref

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells.

Van der Meer JMR, Maas RJA, Guldevall K, ..., Hobo W, Dolstra H

Cancer Immunol. Immunother. 70 (5) 1305-1321 [2021-05-00; online 2020-11-03]

Year 2020

PubMed DOI Crossref

Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade.

Natoli M, Bonito N, Robinson JD, Ghaem-Maghami S, Mao Y

Cancer Immunol. Immunother. 69 (8) 1391-1401 [2020-08-00; online 2020-03-21]

SciLifeLab Fellow Yumeng Mao

PubMed DOI Crossref

Correction to: Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade.

Natoli M, Bonito N, Robinson JD, Ghaem-Maghami S, Mao Y

Cancer Immunol. Immunother. 69 (8) 1403-1408 [2020-08-00; online 2020-06-20]

Year 2014

PubMed DOI Crossref

Altered chemokine production and accumulation of regulatory T cells in intestinal adenomas of APC(Min/+) mice.

Akeus P, Langenes V, von Mentzer A, ..., Raghavan S, Quiding-Järbrink M

Cancer Immunol. Immunother. 63 (8) 807-819 [2014-08-00; online 2014-04-29]

Astrid von Mentzer DDLS Fellow

PubMed DOI Crossref

Immunomodulatory activity of commonly used drugs on Fc-receptor-mediated human natural killer cell activation.

Theorell J, Gustavsson AL, Tesi B, ..., Lundbäck T, Bryceson YT

Cancer Immunol. Immunother. 63 (6) 627-641 [2014-06-00; online 2014-03-30]

PubMed DOI Crossref

Enhanced therapeutic anti-tumor immunity induced by co-administration of 5-fluorouracil and adenovirus expressing CD40 ligand.

Liljenfeldt L, Gkirtzimanaki K, Vyrla D, ..., Loskog AS, Eliopoulos AG

Cancer Immunol. Immunother. 63 (3) 273-282 [2014-03-00; online 2013-12-20]

Year 2012

PubMed DOI Crossref

Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines.

Poschke I, Mao Y, Adamson L, ..., Masucci G, Kiessling R

Cancer Immunol. Immunother. 61 (6) 827-838 [2012-06-00; online 2011-11-12]

SciLifeLab Fellow Yumeng Mao